Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Onconetix, Inc. Director's Dealing 2024

Feb 21, 2024

35411_dirs_2024-02-21_da84748c-9b03-4592-b17d-11772adb4f21.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Onconetix, Inc. (ONCO)
CIK: 0001782107
Period of Report: 2024-02-16

Reporting Person: SINGH AJIT (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2024-02-16 Common Stock A 3125 Acquired 3125 Direct

Footnotes

F1: Represents a restricted stock award granted to the Reporting Person pursuant to the Issuer's 2022 Equity Incentive Plan, as amended. The award will vest in full on June 14, 2024, so long as the Reporting Person continues to serve as a non-employee director of the Issuer until such date.